Concurrent chemoradiotherapy with cisplatin + S-1 versus cisplatin + other third-generation agents for locally advanced non-small-cell lung cancer: a meta-analysis of individual participant data

BACKGROUND: For decades, concurrent chemo-radiotherapy with cisplatin-based regimen has been a standard therapy for locally advanced stage III non-small-cell lung cancer (NSCLC). We conducted individual-participant-data (IPD) meta-analyses to compare S-1/cisplatin versus other third-generation anti-...

Descripción completa

Detalles Bibliográficos
Autores principales: Taniguchi, Yuri, Okamoto, Hiroaki, Shimokawa, Tsuneo, Sasaki, Tomonari, Seto, Takashi, Niho, Seiji, Ohe, Yuichiro, Saigusa, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744285/
https://www.ncbi.nlm.nih.gov/pubmed/35000608
http://dx.doi.org/10.1186/s12890-022-01828-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744285/
https://www.ncbi.nlm.nih.gov/pubmed/35000608
http://dx.doi.org/10.1186/s12890-022-01828-z

Ejemplares similares